← Back
$TVTX All transactions

Travere Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$191K

Shares

10,000

Price

$19

Filed

Sep 24

Insider

Name

REED ELIZABETH E

Title

Chief Legal Officer and GC

CIK

0001283303

Roles

Officer

Transaction Details

Transaction Date

2025-09-22

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

99,878

Footnotes

Includes 396 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 31, 2025. | This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option grant to the Reporting Person on January 4, 2017 with an expiration date of January 4, 2027. | The stock option is fully vested and exercisable.

Filing Info

Accession No.

0001283303-25-000005

Form Type

4

Issuer CIK

0001438533

REED ELIZABETH E's History

Date Ticker Type Value
2026-04-15 TVTX $218K
2026-04-15 TVTX $66K
2026-04-14 TVTX M $191K
2026-04-14 TVTX M $359K
2026-04-14 TVTX M $116K
2026-04-14 TVTX $1.5M
2026-04-14 TVTX $303K
2026-04-14 TVTX M $0
2026-04-14 TVTX M $0
2026-04-14 TVTX M $0

Other Insiders at TVTX (90d)

Insider Bought Sold Last
LYONS GARY A $329K 2026-04-14
REED ELIZABETH E
Chief Legal Officer and GC
$2.1M 2026-04-15
REED ELIZABETH E / Heerma Peter / Inrig Jula
Chief Legal Officer and GC
$303K 2026-04-14
Baynes Roy D. $1.7M 2026-04-14
ROTE WILLIAM E.
Chief Research Officer
$356K 2026-04-22
Dube Eric M
CHIEF EXECUTIVE OFFICER
$4.5M 2026-04-15
Heerma Peter
CHIEF COMMERCIAL OFFICER
2026-04-13
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
$903K 2026-04-14
Inrig Jula
CHIEF MEDICAL OFFICER
$43K 2026-04-15
Cline Christopher R.
CHIEF FINANCIAL OFFICER
$349K 2026-04-15